BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 222 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2023. The put-call ratio across all filers is 2.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $281,306 | +39.0% | 2,610 | +22.3% | 0.00% | +50.0% |
| Q1 2024 | $202,431 | -71.2% | 2,134 | -72.0% | 0.00% | -77.8% |
| Q4 2023 | $701,854 | +30.8% | 7,609 | -28.8% | 0.01% | +12.5% |
| Q3 2023 | $536,550 | +245.5% | 10,684 | +334.8% | 0.01% | +300.0% |
| Q2 2023 | $155,282 | +105.2% | 2,457 | +46.1% | 0.00% | +100.0% |
| Q1 2023 | $75,673 | +28.2% | 1,682 | +24.9% | 0.00% | 0.0% |
| Q4 2022 | $59,012 | -42.1% | 1,347 | -12.8% | 0.00% | -50.0% |
| Q3 2022 | $102,000 | +52.2% | 1,544 | +17.2% | 0.00% | +100.0% |
| Q2 2022 | $67,000 | +71.8% | 1,317 | +113.5% | 0.00% | 0.0% |
| Q1 2022 | $39,000 | +200.0% | 617 | +414.2% | 0.00% | – |
| Q4 2021 | $13,000 | +8.3% | 120 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -88.8% | 120 | -90.1% | 0.00% | -100.0% |
| Q2 2021 | $107,000 | -100.0% | 1,211 | -61.8% | 0.00% | -33.3% |
| Q1 2021 | $308,220,000 | +513600.0% | 3,170 | +492.5% | 0.00% | +200.0% |
| Q4 2020 | $60,000 | +11.1% | 535 | -7.8% | 0.00% | 0.0% |
| Q3 2020 | $54,000 | +200.0% | 580 | +146.8% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | -33.3% | 235 | -50.5% | 0.00% | 0.0% |
| Q1 2020 | $27,000 | -56.5% | 475 | -39.5% | 0.00% | -50.0% |
| Q4 2019 | $62,000 | – | 785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |